Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms
- PMID: 29706353
- PMCID: PMC5986969
- DOI: 10.1016/j.ajhg.2018.03.014
Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms
Abstract
Despite the increasing diagnostic rate of genomic sequencing, the genetic basis of more than 50% of heritable kidney disease remains unresolved. Kidney organoids differentiated from induced pluripotent stem cells (iPSCs) of individuals affected by inherited renal disease represent a potential, but unvalidated, platform for the functional validation of novel gene variants and investigation of underlying pathogenetic mechanisms. In this study, trio whole-exome sequencing of a prospectively identified nephronophthisis (NPHP) proband and her parents identified compound-heterozygous variants in IFT140, a gene previously associated with NPHP-related ciliopathies. IFT140 plays a key role in retrograde intraflagellar transport, but the precise downstream cellular mechanisms responsible for disease presentation remain unknown. A one-step reprogramming and gene-editing protocol was used to derive both uncorrected proband iPSCs and isogenic gene-corrected iPSCs, which were differentiated to kidney organoids. Proband organoid tubules demonstrated shortened, club-shaped primary cilia, whereas gene correction rescued this phenotype. Differential expression analysis of epithelial cells isolated from organoids suggested downregulation of genes associated with apicobasal polarity, cell-cell junctions, and dynein motor assembly in proband epithelial cells. Matrigel cyst cultures confirmed a polarization defect in proband versus gene-corrected renal epithelium. As such, this study represents a "proof of concept" for using proband-derived iPSCs to model renal disease and illustrates dysfunctional cellular pathways beyond the primary cilium in the setting of IFT140 mutations, which are established for other NPHP genotypes.
Keywords: CRISPR/Cas9; IFT140; cilia; functional genomics; gene correction; induced pluripotent stem cells; kidney organoid; nephronophthisis.
Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Fletcher J., McDonald S., Alexander S.I., Australian and New Zealand Pediatric Nephrology Association (ANZPNA) Prevalence of genetic renal disease in children. Pediatr. Nephrol. 2013;28:251–256. - PubMed
-
- Otto E.A., Ramaswami G., Janssen S., Chaki M., Allen S.J., Zhou W., Airik R., Hurd T.W., Ghosh A.K., Wolf M.T., GPN Study Group Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy. J. Med. Genet. 2011;48:105–116. - PMC - PubMed
-
- Mallett A.J., McCarthy H.J., Ho G., Holman K., Farnsworth E., Patel C., Fletcher J.T., Mallawaarachchi A., Quinlan C., Bennetts B., Alexander S.I. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int. 2017;92:1493–1506. - PubMed
-
- Halbritter J., Porath J.D., Diaz K.A., Braun D.A., Kohl S., Chaki M., Allen S.J., Soliman N.A., Hildebrandt F., Otto E.A., GPN Study Group Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum. Genet. 2013;132:865–884. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
